Ryan Savitz

Becton Dickinson: Riding the Biotech Boom

David,

Great article. I have written a few myself on BDX and have held it for over a year. Great trade playing off the expansion of biotech. Another strong area for growth I feel is in Obama's Healthcare plans to reduce healthcare expenses. Although, Becton's systems and products are extremely expensive and cut into hospital CAPEX, they are essential monitoring devices that will cut down on extra tests that doctors might advise for patients. BDX is able to monitor and provide information on many illnesses at once in a more effective and efficient manner than many other competing devices out in the markets today.